New Delhi, August 4 (IANS) Sun Pharmaceutical Industries Ltd on Tuesday announced the launch of Favipiravir, under brand name FluGuard, at Rs 35 per tablet for the treatment of mild to moderate cases of Covid-1
Sunday, 12th October, 2025
